Tumor-suppressive activity of retinoic acid receptor-β in cancer
- 22 December 2006
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 253 (1), 14-24
- https://doi.org/10.1016/j.canlet.2006.11.019
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- Dimerization-induced corepressor binding and relaxed DNA-binding specificity are critical for PML/RARA-induced immortalizationProceedings of the National Academy of Sciences, 2006
- 5-Aza-2′-deoxycytidine induces retinoic acid receptor-β2 demethylation and growth inhibition in esophageal squamous carcinoma cellsCancer Letters, 2005
- Receptor-selective retinoids inhibit the growth of normal and malignant breast cells by inducing G1 cell cycle blockadeBreast Cancer Research and Treatment, 2005
- Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-β2 expressionOncogene, 2005
- An EGF receptor inhibitor induces RAR-β expression in breast and ovarian cancer cellsBiochemical and Biophysical Research Communications, 2005
- QuantitativeRARβ2HypermethylationClinical Cancer Research, 2004
- Prediction of Mammalian MicroRNA TargetsCell, 2003
- Induction of retinoic acid receptor-β suppresses cyclooxygenase-2 expression in esophageal cancer cellsOncogene, 2002
- Detection of Nuclear Retinoic Acid Receptor mRNA in Histological Tissue Sections Using Nonradioactive In Situ Hybridization HistochemistryDiagnostic Molecular Pathology, 1994
- 13-cis-Retinoic Acid in the Treatment of Oral LeukoplakiaNew England Journal of Medicine, 1986